+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans

Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans

Journal of Infectious Diseases 169(2): 477

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 034181198

Download citation: RISBibTeXText

PMID: 8106789

DOI: 10.1093/infdis/169.2.477

Related references

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model. Virology 500: 209-217, 2017

Cold-adapted recombinant influenza A virus vaccines in seronegative young children. Journal of Infectious Diseases 146(1): 71-79, 1982

Recombinant cold-adapted attenuated influenza A vaccines for use in children: molecular genetic analysis of the cold-adapted donor and recombinants. Infection and Immunity 44(3): 730-733, 1984

Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines. Journal of Infectious Diseases 136(1): 17-25, 1977

Recombinant cold-adapted attenuated influenza A vaccines for use in children: reactogenicity and antigenic activity of cold-adapted recombinants and analysis of isolates from the vaccinees. Infection and Immunity 44(3): 734-739, 1984

Evaluation of influenza a alaska 6 77 h 3n 2 cold adapted recombinant viruses derived from influenza a ann arbor 6 60 cold adapted donor virus in adult sero negative volunteers. Infection & Immunity 32(2): 693-697, 1981

Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. Journal of Infectious Diseases 172(1): 253-257, 1995

Infectivity and reactogenicity of reassortant cold-adapted influenza A/Korea/1/82 vaccines obtained from the USA and USSR. Bulletin of the World Health Organization 65(3): 295-301, 1987

Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?. Drugs and Aging 21(6): 349-359, 2004

Intranasal Cold-Adapted Influenza Virus Vaccine Combined with Inactivated Influenza Virus Vaccines. Drugs & Aging 21(6): 349-359, 2004

Development of cold-adapted recombinant live, attenuated influenza A vaccines in the U.S.A. and U.S.S.R. Antiviral Research 1(6): 339-365, 1982

Development of cold adapted recombinant live attenuated influenza a vaccines in the usa and ussr. Antiviral Research: 339-366, 1982

Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infection and Immunity 23(2): 253-259, 1979

Safety and high immunogenic potency for 3 15 year old children of mono vaccines and bi vaccines from influenza a brazil 11 78 h 1n 1 and a bangkok 1 79 h 3n 2 virus recombinants obtained on the basis of a special donor of attenuation a cold adapted a leningrad 134 47 57 h 2n 2 virus/. Voprosy Virusologii (6): 710-714, 1983

Placebo controlled trial of live attenuated cold adapted influenza a vaccines h 1n 1 and h 3n 2 vs. inactivated whole virus influenza a h 3n 2 vaccine. Pediatric Research 18(4 Part 2): 274A, 1984